Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
Objectives To evaluate the potential of immunosuppressed patients to mount B-cell and T-cell responses to COVID-19 booster vaccination (third vaccination).Methods Patients with primary immunodeficiency (PID), immune-mediated inflammatory diseases (IMIDs) on CD20-depleting treatment with rituximab (R...
Main Authors: | Frank Behrens, Harald Burkhardt, Michaela Koehm, Sandra Ciesek, Maximilian Klippstein, Stephanie Dauth, Konstantin Hallmann, Niko Kohmer, Gerd Geisslinger, Holger F Rabenau |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-09-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/3/e003094.full |
Similar Items
-
Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
by: Niko Kohmer, et al.
Published: (2021-05-01) -
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
by: Niko Kohmer, et al.
Published: (2023-03-01) -
Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.
by: Liston, A, et al.
Published: (2008) -
Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity
by: Ko-Jen Li, et al.
Published: (2021-02-01) -
Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
by: Sammy Patyna, et al.
Published: (2022-04-01)